Does OBINUTUZUMAB Cause Peripheral swelling? 54 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Peripheral swelling have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.4% of all adverse event reports for OBINUTUZUMAB.
54
Reports of Peripheral swelling with OBINUTUZUMAB
0.4%
of all OBINUTUZUMAB reports
15
Deaths
18
Hospitalizations
How Dangerous Is Peripheral swelling From OBINUTUZUMAB?
Of the 54 reports, 15 (27.8%) resulted in death, 18 (33.3%) required hospitalization, and 1 (1.9%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 54 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which OBINUTUZUMAB Alternatives Have Lower Peripheral swelling Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE